Valuation: Stem Cells Spin S.A.

Market Cap	20.67M 5.31M 4.72M 4.41M 4.02M 7.57M 512M 7.68M 53.39M 261M 19.95M 19.52M 837M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	20.75M 5.34M 4.74M 4.43M 4.04M 7.6M 514M 7.71M 53.61M 262M 20.03M 19.6M 840M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	57.28%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: Stem Cells Spin S.A.

08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	-.--%	-.--%	+22.55%	+25.00%	5.38M
WUXI APPTEC CO., LTD.	+4.16%	-0.36%	+49.37%	+94.17%	74.46B
ARGENX SE	-0.61%	+0.81%	+27.25%	+80.21%	60.14B
LONZA GROUP AG	-2.54%	-1.65%	+4.86%	+33.32%	48.15B
IQVIA HOLDINGS INC.	-2.63%	-4.87%	+28.39%	+34.95%	44.25B
REVOLUTION MEDICINES, INC.	+1.14%	+3.88%	+352.71%	+693.33%	43.99B
BEONE MEDICINES AG	-1.55%	+0.08%	+7.49%	+101.83%	41.61B
CELLTRION, INC.	+3.32%	+3.49%	+11.18%	+51.23%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+22.78%	29.31B
INSMED INCORPORATED	-3.76%	-9.32%	-25.16%	+334.45%	24.93B
Average	+0.26%	+2.41%	+51.54%	+147.13%	39.68B
Weighted average by Cap.	+0.45%	+1.83%	+59.02%	+151.88%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-16 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
01/10/26	PLN 0.4700	-6.00%	256
30/09/26	PLN 0.5000	0.00%	200
29/09/26	PLN 0.5000	+4.17%	30
25/09/26	PLN 0.4800	-4.00%	1,400

End-of-day quote Warsaw S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. 01/10/2026			5-day change	1st Jan Change
0.4700 ^PLN	-6.00%		-6.00%	+15.76%

1 month	+5.93%
3 months	+25.00%
6 months	+28.87%
Current year	+23.15%

1 week	0.48	0.5
1 month	0.47	0.52
Current year	0.33	0.54
1 year	0.28	0.54
3 years	0.14	0.82
5 years	0.14	1.12
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 13.95K 12.39K 11.59K 10.56K 19.88K 1.34M 20.16K 140K 684K 52.39K 51.25K 2.2M	65.74K 16.9K 15.01K 14.04K 12.79K 24.08K 1.63M 24.41K 170K 829K 63.45K 62.07K 2.66M
Net income	-520K -134K -119K -111K -101K -191K -12.88M -193K -1.34M -6.56M -502K -491K -21.06M	-526K -135K -120K -112K -102K -193K -13.01M -195K -1.36M -6.63M -507K -496K -21.28M
Net Debt	69.28K 17.81K 15.82K 14.79K 13.48K 25.38K 1.71M 25.73K 179K 873K 66.87K 65.42K 2.81M	84.58K 21.74K 19.31K 18.06K 16.46K 30.99K 2.09M 31.41K 219K 1.07M 81.64K 79.87K 3.42M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news: Stem Cells Spin S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes